A Compassionate Use (CU) Program of Odronextamab
Status
Conditions
High-Grade B-Cell Lymphoma (HGBCL)
Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
Diffuse Large B-Cell Lymphoma (DLBCL)
B-Cell Non-Hodgkin Lymphoma (NHL)
Treatments
Drug: Odronextamab
Details and patient eligibility
About
Provide compassionate use of odronextamab
Sex
All
Volunteers
No Healthy Volunteers
Inclusion and exclusion criteria
Trial contacts and locations
0
Loading...
Central trial contact
Requests for compassionate use must be initiated by a treating physician Physicians should contact
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems